Estimated delivery in United States, on Tuesday 18 Mar 2025
Product Information
Name:
D228
Description:
D228 is an orally-administered anti-inflammatory compound effective against inflammatory bowel disease (IBD). It reduces ConA-induced T lymphocyte proliferation (IC50: 42.85 μM) and LPS-induced B lymphocyte proliferation (IC50: 3.15 μM). D228 alleviates inflammation in IBD models induced by DSS by downregulating the MyD88/TRAF6/p38 signaling pathway.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
484.45
Formula:
C22H28O12
Color/Form:
Liquid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T200551 D228
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
